Japan In Vitro Diagnostics (IVD) market is predicted to surpass US$ 5.5 Billion by 2028. Japan is one of the leading clinical laboratory markets in the Asia–Pacific region, and one of the largest markets for in vitro diagnostics (IVD) in the world. Japan is facing the challenges of fighting with infectious disease including HBV, TB, HCV, and HIV, as well as various chronic disease and cancer. The population of Japan is aging rapidly. For instance, as of November 2022, close to 36.5 million people in Japan were estimated to be within the age group 65 and over. Thus, Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.

Japan In Vitro Diagnostics (IVD) Market – Recent Developments

  • In April 2023, Oxford Nanopore Technologies plc, and bioM?rieux SA teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
  • In December 2022, bioM?rieux announced the CE-marking of VIDAS KUBE, the next generation automated immunoassay system for the VIDAS range.
  • In July 2022, DiaCarta Inc., a molecular diagnostics company announced that the company has received CE-IVD Mark for its newly developed QuantiVirus SARS-CoV-2 & Flu A/B test.



By Segment Japan IVD Market and Forecast – Key Takeaway

  • On segment basis, Genetic Testing and Clinical Chemistry are the leading segment of the Japan IVD market.
  • Immunoassay stands at the 3rd leading spot in the Japan in vitro diagnostics market.
  • Tumor Marker and Hematology segments are competing closely with each other to grab maximum share of the pie.
  • Infectious disease segment contributed over 10 percent to the Japan IVD market in 2022.



Japan IVD Market – Company Analysis

  • In the Japan IVD market, Roche Diagnostics is the leader, followed by Sysmex Corporation.
  • Abbott Laboratories, Thermo Fisher Scientific Inc., and Danaher Corporation are the other top three players in the Japan IVD market.
  • In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
  • In April 2023, bioM?rieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System.


The report titled “Japan In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Major Deals, Trends and Recent Developments – Forecast to 2028” provides a comprehensive assessment of the fast–evolving, high–growth Japan IVD Market.

This 200 Page report with 42 Figures and 4 Tables has been analyzed from 8 View Points:

1) Japan In-Vitro Diagnostics (IVD) Market and Forecast (2008 – 2028)
2) Japan IVD Market Share and Forecast (2008 – 2028)
3) Japan IVD Market & Forecast – By Segment (2008 – 2028)
4) Japan IVD Market & Forecast – Company Sales Analysis (2014 – 2028)
5) Japan IVD Market – Major Deals
6) Japan IVD Market – Recent Developments
7) Registration for In Vitro Diagnostic Devices in Japan
8) Japan IVD Market - Drivers & Challenges

Japan IVD Market – By Segment

1. Urine & Feces
2. Hematology
3. Clinical Chemistry
4. SMBG
5. Tumor Marker
6. Immunoassay
7. Infectious Disease
8. Microbiology
9. Pathology
10. Genetic Testing
11. Others

Japan IVD Sales & Forecast – By Company

1. Roche Diagnostics
2. Abbott Laboratories
3. Danaher Corporation
4. Biomerieux
5. Sysmex Corporation
6. Bio-Rad Laboratories, Inc
7. Becton Dickinson Company
8. Thermo Fisher Scientific Inc.
9. Others

Data Source
The key player employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non–printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.